MONTEREY, Calif. — Fewer adverse events overall were reported in eyes receiving Allergan’s Xen gel stent to treat glaucoma vs. eyes undergoing trabeculectomy at 12 months in the Gold Standard Pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback